abbvie glp-1 receptor agonists weight management diabetes treatments Clinical of Regain and Cardiometabolic Consequences After Discontinuation of GLP‐1 - Shah - 2026 - Diabetes, Obesity and Metabolism The Sustained Effects of a
Description
153 MaliniNARoy GeorgeK

Retatrutide targets all three simultaneously

[DOI] [PubMed] [Google Scholar] 252.Leon N., et al

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

Am J Clin Exp Immunol

August 2, 2024
